259 related articles for article (PubMed ID: 21762728)
1. Cross-talk between the complement and the kinin system in vascular permeability.
Bossi F; Peerschke EI; Ghebrehiwet B; Tedesco F
Immunol Lett; 2011 Oct; 140(1-2):7-13. PubMed ID: 21762728
[TBL] [Abstract][Full Text] [Related]
2. The Role of Complement in Hereditary Angioedema.
Levi M; Cohn DM
Transfus Med Rev; 2019 Oct; 33(4):243-247. PubMed ID: 31676220
[TBL] [Abstract][Full Text] [Related]
3. Hereditary angioedema attack: what happens to vasoactive mediators?
Ferrara AL; Bova M; Petraroli A; Veszeli N; Galdiero MR; Braile M; Marone G; Cristinziano L; Marcella S; Modestino L; Farkas H; Loffredo S
Int Immunopharmacol; 2020 Jan; 78():106079. PubMed ID: 31841756
[TBL] [Abstract][Full Text] [Related]
4. Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency.
Bossi F; Fischetti F; Regoli D; Durigutto P; Frossi B; Gobeil F; Ghebrehiwet B; Peerschke EI; Cicardi M; Tedesco F
J Allergy Clin Immunol; 2009 Dec; 124(6):1303-10.e4. PubMed ID: 19796797
[TBL] [Abstract][Full Text] [Related]
5. Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.
Charignon D; Späth P; Martin L; Drouet C
Expert Opin Pharmacother; 2012 Oct; 13(15):2233-47. PubMed ID: 22970904
[TBL] [Abstract][Full Text] [Related]
6. Update on therapeutic developments for hereditary angioedema.
Christiansen SC; Zuraw BL
Allergy Asthma Proc; 2009; 30(5):500-5. PubMed ID: 19843404
[TBL] [Abstract][Full Text] [Related]
7. The plasma bradykinin-forming pathways and its interrelationships with complement.
Kaplan AP; Ghebrehiwet B
Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
[TBL] [Abstract][Full Text] [Related]
8. Current pharmacotherapy of bradykinin-mediated angioedema.
Farkas H
Expert Opin Pharmacother; 2013 Apr; 14(5):571-86. PubMed ID: 23480060
[TBL] [Abstract][Full Text] [Related]
9. Role of the B1 bradykinin receptor and gC1qR/p33 in angioedema.
Bossi F; Tedesco F
Immunol Allergy Clin North Am; 2013 Nov; 33(4):535-44. PubMed ID: 24176217
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cells are a target of both complement and kinin system.
Bossi F; Bulla R; Tedesco F
Int Immunopharmacol; 2008 Feb; 8(2):143-7. PubMed ID: 18182217
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.
Zanichelli A; Mansi M; Periti G; Cicardi M
Expert Rev Clin Immunol; 2013 May; 9(5):477-88. PubMed ID: 23634741
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation.
Lopatko Fagerström I; Ståhl AL; Mossberg M; Tati R; Kristoffersson AC; Kahn R; Bascands JL; Klein J; Schanstra JP; Segelmark M; Karpman D
EBioMedicine; 2019 Sep; 47():319-328. PubMed ID: 31444145
[TBL] [Abstract][Full Text] [Related]
13. Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management.
Bork K; Davis-Lorton M
Eur Ann Allergy Clin Immunol; 2013 Feb; 45(1):7-16. PubMed ID: 23678554
[TBL] [Abstract][Full Text] [Related]
14. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the management of hereditary angioedema.
Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
[TBL] [Abstract][Full Text] [Related]
16. HAE Pathophysiology and Underlying Mechanisms.
Zuraw BL; Christiansen SC
Clin Rev Allergy Immunol; 2016 Oct; 51(2):216-29. PubMed ID: 27459852
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of bradykinin receptors on human synovial tissue.
Cassim B; Naidoo S; Ramsaroop R; Bhoola KD
Immunopharmacology; 1997 Jun; 36(2-3):121-5. PubMed ID: 9228535
[TBL] [Abstract][Full Text] [Related]
18. Involvement of bradykinin B1 and B2 receptors in human PMN elastase release and increase in endothelial cell monolayer permeability.
Carl VS; Moore EE; Moore FA; Whalley ET
Immunopharmacology; 1996 Jun; 33(1-3):325-9. PubMed ID: 8856176
[TBL] [Abstract][Full Text] [Related]
19. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
Kaplan AP; Joseph K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087
[TBL] [Abstract][Full Text] [Related]
20. Vasomotor and permeability effects of bradykinin in the cerebral microcirculation.
Wahl M; Whalley ET; Unterberg A; Schilling L; Parsons AA; Baethmann A; Young AR
Immunopharmacology; 1996 Jun; 33(1-3):257-63. PubMed ID: 8856159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
